GlassScriptPhysician profile
Andrea C Farber
NPI 1073949061
$638.24
in general payments reported to CMS, 2019-2025
17 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.10 · 2020: $24.18 · 2021: $21.42 · 2022: $17.39 · 2023: $145 · 2024: $179 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $124.89 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $63.33 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $62.26 | 2023-2025 | Vyzulta, Miebo, Infuse |
| Oyster Point Pharma, INC. | $45.98 | 2023-2025 | Tyrvaya, Ryzumvi |
| Alimera Sciences, INC. | $34.13 | 2023-2024 | Iluvien, Yutiq |
| Johnson & Johnson Surgical Vision, INC. | $32.83 | 2022-2024 | Lipiflow System Activator II (Disposable |
| Glaukos Corporation | $32.49 | 2024 | Ce-Marked Kxla System |
| Biotissue Holdings INC. | $32.07 | 2024-2025 | |
| Abbvie INC. | $29.84 | 2024 | |
| Astellas Pharma US INC | $28.14 | 2023 | |
| Novartis Pharmaceuticals Corporation | $26.24 | 2023 | |
| Aerie Pharmaceuticals, INC. | $24.64 | 2019 | |
| Optos, INC. | $23.73 | 2019 | |
| Horizon Therapeutics Plc | $22.69 | 2023 | Tepezza |
| Dompe US, INC. | $20.82 | 2025 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.79 | 2024 | Vabysmo |
| Johnson & Johnson Vision Care, INC. | $14.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Farber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.